[Biosynthesis of simvastatin--a mini-review]

Area of Science:

• Biotechnology
• Organic Chemistry
• Pharmacology

Background:

• Simvastatin, a derivative of lovastatin, is crucial for treating hypercholesterolemia.
• Traditional chemical synthesis of simvastatin involves harsh conditions, difficult purification, and environmental concerns.
• Advancements in lovastatin biosynthesis research have spurred interest in biological simvastatin production.

Purpose of the Study:

• To compare the efficiency and feasibility of chemical versus biological routes for simvastatin production.
• To explore alternative, more sustainable methods for simvastatin manufacturing.

Main Methods:

• Review and comparison of traditional chemical synthesis (direct alkylation of lovastatin) with emerging biological methods.
• Investigated direct fermentation using combinational biosynthesis.
• Examined enzymatic synthesis from monacolin J using acyltransferase LovD.

Main Results:

• Chemical synthesis presents challenges including rigid reaction conditions, difficult purification, and high environmental/labor protection pressures.
• Biological routes, including direct fermentation and enzymatic synthesis, show promise for simvastatin production.
• Combinational biosynthesis and the use of LovD offer alternative pathways.

Conclusions:

• Biological production routes, particularly direct fermentation and enzymatic synthesis, present a viable and potentially superior alternative to traditional chemical methods for simvastatin.
• These biotechnological approaches may alleviate the environmental and operational burdens associated with chemical synthesis.